Covidien Guides FY13 Pharma Sales Up 1-4%, 2013 Sales Up 3-6%

Covidien COV, a leading global provider of healthcare products, today outlined the initiatives, strategies and innovations that are expected to drive the Company's growth in 2013 and beyond at a meeting held here for the investment community. Chairman, President and CEO José (Joe) E. Almeida spoke about Covidien's recent accomplishments, the current market environment for medical devices and the opportunities presented by the Company's recent portfolio additions which will drive the growth over the next few years.